This website is intended for UK healthcare professionals.
The Adverse Event Reporting and a link to the Prescribing Information can be found at the bottom of the page.

Takeda ADHD portfolio resources

Elvanse logo

Watch the pro-drug technology video which
explains how the Elvanse mode of action works

Request a call from a Takeda representative to discuss Elvanse

Icon

Request here

View the Elvanse patient booklet

Icon

A booklet for child & adolescent patients who have been prescribed Elvanse explaining what the medication is, what they can expect from it, and how it should be taken.

Download here

Intuniv logo

Watch the Intuniv mode of action video

Request a call from a Takeda representative to discuss Intuniv

Icon

Request here

View the Intuniv initiation checklist

Icon

A checklist with a number of preliminary assessments for child & adolescent patients to complete before starting INTUNIV to help ensure suitability.

Download here

Equasym XL logo

Request a call from a Takeda representative to discuss Equasym XL

Icon

Request here

View the Equasym XL patient booklet

Icon

A booklet for child & adolescent patients who have been prescribed Equasym XL explaining what the medication is, what they can expect from it, and how it should be taken.

Download here

ADHD logo

ADHD e-forum

Icon

Discover innovative resources, interactive digital tools, and latest information to support you and your patients with ADHD

Visit here
Clicking this link will take you to a website initiated, funded and developed by Takeda. Registration is required to enter the ADHD eForum website.

ADHD & You

Icon

Resources for your patients where they can find out more about ADHD.

Visit here
Clicking this link will take you to a website initiated, funded and developed by Takeda

Takeda

Elvanse® Prescribing Information

Equasym® XL Prescribing Information

Intuniv® Prescribing Information

For Adverse Event Reporting related to
Elvanse and Equasym XL:

Adverse events should be reported to the Medicines and Healthcare products Regulatory Agency.
Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Takeda at: AE.GBR‑IRL@takeda.com.

For Adverse Event Reporting related to
Intuniv:

▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Takeda at: AE.GBR‑IRL@takeda.com.

Terms of Use

Privacy Policy

Contact Us

C-APROM/GB/ELVS/0042 | March 2023